ducovest

ZHU:CA:TSX-BMO Equal Weight US Health Care Index ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 44.21

Change

0.00 (0.00)%

Market Cap

CAD 0.01B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Company Website : http://www.bmo.com/gam/ca

Currency: CAD

Country : Canada

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-11 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

N/A

 CAD 3.43B
ZWU:CA BMO Covered Call Utilities ETF

N/A

 CAD 1.81B
XIT:CA iShares S&P/TSX Capped Informa..

N/A

 CAD 0.78B
TXF:CA First Asset Tech Giants Covere..

N/A

 CAD 0.67B
HTA:CA Harvest Tech Achievers Growth ..

N/A

 CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

N/A

 CAD 0.54B
ZUT:CA BMO Equal Weight Utilities Ind..

N/A

 CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

N/A

 CAD 0.37B
CWW:CA iShares Global Water Common Cl..

N/A

 CAD 0.31B
COW:CA iShares Global Agriculture Com..

N/A

 CAD 0.27B

ETFs Containing ZHU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.46% 97% N/A 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.46% 97% N/A 82% B
Trailing 12 Months  
Capital Gain 5.79% 37% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.79% 31% F 29% F
Trailing 5 Years  
Capital Gain 27.77% 46% F 61% D-
Dividend Return 2.28% 15% F 5% F
Total Return 30.06% 31% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 4.79% 37% F 50% F
Dividend Return 4.82% 29% F 45% F
Total Return 0.03% 12% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 11.34% 77% C+ 69% C-
Risk Adjusted Return 42.50% 31% F 54% F
Market Capitalization 0.01B 12% F 11% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.